Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors
This study has been completed.
Study NCT00165802   Information provided by Eisai Inc.

First Received on September 12, 2005.   Last Updated on May 20, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer, Malignant Tumors
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
E7974
Sponsors listed in this trial
Eisai Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services